Factors associated with non-epithelial ovarian cancer among Mexican women: A matched case-control study

International Journal of Gynecological Cancer

Volumn 13, Issue 6, 2003, Pages 756-763

  Sanchez Zamorano, Luisa María ^a   Salazar Martinez, E ^a,b   Escudero De Los Rios, P ^c   Gonzalez Lira, G ^b   Flores Luna, L ^a   Lazcano Ponce, E C ^a  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c HOSPITAL DE ONCOLOGÍA   (Mexico)

Author keywords

Germ cells; Non epithelial ovarian cancer; Parity; Stromal sex cord

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GERM CELL TUMOR; GYNECOLOGIC CANCER; HUMAN; MENARCHE; MEXICO; OVARY CANCER; PARITY; PHYSICAL ACTIVITY; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; STROMA CELL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CARCINOMA; CASE-CONTROL STUDIES; CHILD; FEMALE; HUMANS; MEXICO; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; ODDS RATIO; OVARIAN NEOPLASMS; PARITY; PREGNANCY; RISK FACTORS; STROMAL CELLS;

EID: 1242294397     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2003.13604.x     Document Type: Article

References (27)

1. Young RC, Knapp RC, Fuks Z, Disaia PJ. Cap 33 Cáncer de ovario: Cáncer, principios y práctica de oncología. In: Vincent T, ed. Devita, 2d edn, Salvat, Barcelona. 1988: 1008-18.
2. Merino MJ, Jaffe G. Age contrast in ovarian pathology. Cancer 1993;71(Suppl.):537-44.
3. Horn-Ross PL, Whittemore AS, Harris R, Itnyre J. Collaborative Ovarian Cancer Group, 1992 characteristics relating to ovarian cancer risk. Collaborative analysis of 12 U.S. case-control studies. VI. Nonepithelial cancers among adults. Epidemiology 1992;3:490-5.
4. Levi F, Franceschi LF, La Vecchia C, Ruzicka J, Gloor E, Randimbison L. Epidemiologic pathology of ovarian cancer from the Vaud cancer registry, Switzerland. Ann Oncol 1993;4:289-94.
5. Germá JR, Izquierdo MA, Seguí MA, Climent MA, Ojeda B, Alonso C. Malignant ovarian germ cell tumors. The experience at the hospital de la Santa Creu i Sant Pau. Gynecol Oncol 1992;45:153-9.
6. Perrin LC, Low J, Nicklin JL, Ward BG, Crandon AJ. Fertility and ovarian function after conservative surgery for germ cell tumors of the ovary. Aust N Z J Obstet Gynecol 1999;39:243-5.
7. Ayhan A, Bildirici I, Gunalp S, Yuce K. Pure dysgerminoma of the ovary: a review of 45 well staged cases. Eur J Gynaecol Oncol 2000;21:98-101.
8. Kanazawa K, Suzuki T, Sakumoto K. Treatment of malignant ovarian germ cell tumors with preservation of fertility: reproductive performance after persistent remission. Am J Clin Oncol 2000;23:244-8.
9. Tewari K, Cappuccini F, Disaia PJ, Berman ML, Manetta A, Kohler MF. Malignant germ cell tumors of the ovary. Obstet Gynecol 2000;95:128-33.
10. Disaia PJ, Creasman WT. Ginecología oncológica, 3d edn, Editorial Médica Panamericana, Mexico. 1991: 217-329.
11. Gribbon M, Ein SH, Mancer K. Pediatric malignant ovarian tumors: a 43-year review. J Pediatr Surg 1992;27: 180-4.
12. Walker AH, Ross RK, Haile RWC, Herderson BE. Hormonal factors and risk of ovarian germ cell cancer in young women. Br J Cancer 1988;57:418-22.
13. Secretaria de Salud. Registro histopatológico de neoplasias en México. Dirección General Epidemiología 1998: 47-54.
14. Salazar-Martinez E, Lazcano-Ponce EC, Gonzalez-Lira-Lira G, Escudero-De los Rios P, Salmeron-Castro J, Hernandez-Avila M. Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico. Cancer Res 1999;59:3658-62.
15. Ainsworth BE, Haskell WL, Leon AS, Jacobs R Jr, Montoye HJ, Sallis JF, Paffenborger RS Jr. Compendium of physical activities: classification of energy cost of human physical activities. Med Sci Sports Exercise 1993;3:71-80.
16. Quetelet LAJ. Phisique Sociale, Vol. 2, Brussels: C Mugoordt, 1869: 92.
17. Adami HO, Hsich CC, Lambe M et al. Parity, age at first childbirth, and risk of ovarian cancer. Lancet 1994; 344:1250-4.
18. Organización Mundial de la Salud Organización Panamericana de la Salud. Situación de la salud en las américas: Indicadores básicos, http://www.paho.org/sha., 2000.
19. Raney RB, Sinclair L, Uri A, Schnaufer L, Cooper A, Littman P. Malignant ovarian tumors in children and adolescents. Cancer 1987;59:1214-20.
20. Imai A, Furui T, Tamaya T. Gynecologic tumors and symptoms in childhood and adolescence; 10 years' experience. Int J Gynecol Obstet 1994;45:227-34.
21. Menczer J, Sadetzki S, Murad H, Barda G, Andreev H, Barchana M. Childhood and adolescent ovarian malignant tumors in Israel. A nationwide study. Acta Obstet Gynecol Scand 1999;78:813-7.
22. Rothman KJ, Greenland S, 1998. Modern Epidemiology. Chapter 10, 16 and 21. 2d edn, Lippincott-Raven Publishers, Philadelphia, PA. 1998 pp: 147-162, 281-300, 401-434.
23. Hennesy S, Biker WB, Berlin JA, Strom BL. Factors influencing the optimal-to-case ratio in matched case-control studies. Am J Epidemiol 1999;149:195-197.
24. Akre J. Infant feeding, the physiological basis. Bulletin of the WHO Geneva, Switzerland, 1989: 12-3.
25. Yen SSC, Jaffe RB. Reproductive endocrinology, 3d edn. New York: WB. Saunders, 1991: 181-273.
26. De Palo G, Pilotti S, Kenda R et al. Natural history of dysgerminoma. Am J Obstet Gynecol 1982;143:799-807.
27. Yang GC, Mesia AF. Fine-needle aspiration cytology of malignant fibrothecoma of the ovary. Diagn Cytopathol 1999;21:284-6.